English-to-Spanish translation equivalence of oncology clinical trial informed consent forms
Source article: Evaluating Artificial Intelligence Translation Tools for Language Equivalence of Oncology-Informed Consent Forms From English to Spanish
Abstract: Approximately 8% of the US population speaks primary languages other than English. Limited English proficiency (LEP) contributes to under-representation of Hispanic patients in oncology clinical trials. Although certified translation services exist, they are time-consuming and costly. Artificial intelligence (AI)-generated translations of informed consent forms (ICFs) could provide low-cost alternatives, but data on accuracy and safety remain limited. We evaluated language equivalence of English-to-Spanish trans…
Negative state: both sides are scored from claims and sources, not community votes.

"Friends of Cancer Research" by MDGovpics is licensed under CC BY 2.0. To view a copy of this license, visit https://creativecommons.org/licenses/by/2.0/.
On August 5, 2026, a peer-reviewed study in JCO Oncology Practice evaluated AI translation of three oncology clinical trial informed consent forms from English to Spanish, comparing DeepL Pro, ChatGPT-4o, and a medically trained model Med_English2Spanish against certified translations using five equivalence domains scored by two bilingual physicians.
The findings matter because limited English proficiency contributes to under-representation of Hispanic patients in oncology trials, and low-cost AI could reduce barriers, but variable performance and safety concerns mean human review remains required and broader validation across more forms, languages, and raters is still needed.
- Study compared DeepL Pro, ChatGPT-4o, and Med_English2Spanish against certified translations for three oncology ICFs.
- Equivalence scored on five-point Likert scale across Semantic, Idiomatic, Experiential, Conceptual, and Safety domains by two bilingual physicians.
- Certified translations highest at mean 4.99, ChatGPT-4o at 4.89, DeepL Pro at 4.43, Med_English2Spanish lowest at 3.32.
- Authors concluded AI translations not suitable for clinical deployment without human review but warrant further study to reduce language barriers.
General-purpose AI tool ChatGPT-4o achieved near-certified translation equivalence for English-to-Spanish oncology informed consent forms.
Low-cost AI translations of oncology informed consent forms showed variable language equivalence and remain unsuitable for clinical use without human review.
The rundown
Researchers tested English-to-Spanish translation of three oncology trial ICFs using DeepL Pro, ChatGPT-4o, and Med_English2Spanish versus certified translations, scoring five domains on a five-point Likert scale.
Two bilingual board-certified physicians scored independently with high inter-rater agreement (weighted kappa 0.95), finding certified translations at 4.99 mean, ChatGPT-4o at 4.89, DeepL Pro at 4.43, and Med_English2Spanish at 3.32.
Exploratory evaluation limited to three oncology ICFs and two physician raters, with variable equivalence across tools and domains.
Sources
- Peer-reviewedJCO Oncology Practice2026-08-05
How should this claim be treated?
ace
The debate